The roles of Th cells in myocardial infarction | Cell Death Discovery – Nature.com

Zhang L, Hailati J, Ma X, Liu J, Liu Z, Yang Y, et al. Analysis of risk factors for different subtypes of acute coronary syndrome. J Int Med Res. 2021;49:3000605211008326.

CAS PubMed Google Scholar

Shi LY, Han YS, Chen J, Li ZB, Li JC, Jiang TT. Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction. Ann Transl Med. 2021;9:743.

Article CAS PubMed PubMed Central Google Scholar

Wei P, Zhuo S, Fu Q, Wang H, Zong B, Cao B, et al. The efficacy and safety of the short-term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI. Clin Transl Sci. 2022;15:47789.

Article CAS PubMed Google Scholar

Clay S, Blankenship JC. Left ventricular thrombus after myocardial infarction: opinions and equipoise. cardiovasc drugs therapy. 2024;5:online ahead of print.

Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16:20312.

Article PubMed Google Scholar

Jung KT, Bapat A, Kim YK, Hucker WJ, Lee K. Therapeutic hypothermia for acute myocardial infarction: a narrative review of evidence from animal and clinical studies. Korean J Anesthesiol. 2022;75:21630.

Article CAS PubMed PubMed Central Google Scholar

Liao Y, Li H, Pi Y, Li Z, Jin S. Cardioprotective effect of IGF-1 against myocardial ischemia/reperfusion injury through activation of PI3K/Akt pathway in rats in vivo. J Int Med Res. 2019;47:388697.

Article CAS PubMed PubMed Central Google Scholar

Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, Lin YH, Hausenloy DJ. Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine 2020;57:102884.

Article PubMed PubMed Central Google Scholar

Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig. 2013;123:92100.

Article CAS PubMed PubMed Central Google Scholar

Zhang Y, Wen W, Liu H. The role of immune cells in cardiac remodeling after myocardial infarction. J Cardiovasc Pharmacol. 2020;76:40713.

Article PubMed PubMed Central Google Scholar

Pluijmert NJ, Atsma DE, Quax PHA. Post-ischemic myocardial inflammatory response: a complex and dynamic process susceptible to immunomodulatory therapies. Front Cardiovasc Med. 2021;8:647785.

Article CAS PubMed PubMed Central Google Scholar

Monsinjon T, Richard V, Fontaine M. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement. Fundamental Clin Pharmacol. 2001;15:293306.

Article CAS Google Scholar

Ong SB, Hernndez-Resndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018;186:7387.

Article CAS PubMed PubMed Central Google Scholar

Lu Q, Yang MF, Liang YJ, Xu J, Xu HM, Nie YQ, et al. Immunology of inflammatory bowel disease: molecular mechanisms and therapeutics. J Inflamm Res. 2022;15:182544.

Article CAS PubMed PubMed Central Google Scholar

Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci USA. 2014;111:1602934.

Article CAS PubMed PubMed Central Google Scholar

Snchez-Hernndez CD, Torres-Alarcn LA, Gonzlez-Corts A, Pen AN. Ischemia/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediators Inflamm. 2020;2020:8405370.

Article PubMed PubMed Central Google Scholar

Boukouaci W, Lauden L, Siewiera J, Dam N, Hocine HR, Khaznadar Z, et al. Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence. Cardiovasc Res. 2014;104:290302.

Article CAS PubMed Google Scholar

Juengpanich S, Shi L, Iranmanesh Y, Chen J, Cheng Z, Khoo AK, et al. The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review. Transl Oncol. 2019;12:1092107.

Article PubMed PubMed Central Google Scholar

Chen S, Chen X, Geng Z, Su J. The horizon of bone organoid: A perspective on construction and application. Bioact Mater. 2022;18:1525.

CAS PubMed PubMed Central Google Scholar

Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H, et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 2012;125:123445.

Article PubMed Google Scholar

Liu H, Gao W, Yuan J, Wu C, Yao K, Zhang L, et al. Exosomes derived from dendritic cells improve cardiac function via activation of CD4(+) T lymphocytes after myocardial infarction. J Mol Cell Cardiol. 2016;91:12333.

Article CAS PubMed Google Scholar

Xue J, Ge H, Lin Z, Wang H, Lin W, Liu Y, et al. The role of dendritic cells regulated by HMGB1/TLR4 signalling pathway in myocardial ischaemia reperfusion injury. J Cell Mol Med. 2019;23:284962.

Article CAS PubMed PubMed Central Google Scholar

Sun Y, Pinto C, Camus S, Duval V, Alayrac P, Zlatanova I, et al. Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice. J Am Coll Cardiol. 2022;79:63247.

Article CAS PubMed Google Scholar

Huang F, Zhang J, Zhou H, Qu T, Wang Y, Jiang K, et al. B cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion. JCI insight. 2024;9.

Wu L, Dalal R, Cao CD, Postoak JL, Yang G, Zhang Q, et al. IL-10-producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction. Proc Natl Acad Sci USA. 2019;116:2167384.

Article CAS PubMed PubMed Central Google Scholar

Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, et al. T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients. J Clin Investig. 2015;125:306376.

Article PubMed PubMed Central Google Scholar

Arjomandnejad M, Dasgupta I, Flotte TR, Keeler AM. Immunogenicity of recombinant adeno-associated virus (AAV) vectors for gene transfer. BioDrugs. 2023;37:31129.

Article CAS PubMed PubMed Central Google Scholar

Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, et al. Targeting cardiac fibrosis with engineered T cells. Nature 2019;573:4303.

Article CAS PubMed PubMed Central Google Scholar

Hofmann U, Frantz S. Role of T-cells in myocardial infarction. Eur Heart J. 2016;37:8739.

Article CAS PubMed Google Scholar

Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 2006;114:205664.

Article CAS PubMed Google Scholar

Ayelign B, Akalu Y, Teferi B, Molla MD, Shibabaw T. Helminth induced immunoregulation and novel therapeutic avenue of allergy. J Asthma Allergy. 2020;13:43951.

Article CAS PubMed PubMed Central Google Scholar

Wei C, Huang L, Zheng Y, Cai X. Selective activation of cannabinoid receptor 2 regulates Treg/Th17 balance to ameliorate neutrophilic asthma in mice. Ann Transl Med. 2021;9:1015.

Article CAS PubMed PubMed Central Google Scholar

Xia Y, Gao D, Wang X, Liu B, Shan X, Sun Y, et al. Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets. Front Immunol. 2024;15:1331609.

Article CAS PubMed PubMed Central Google Scholar

Xia N, Lu Y, Gu M, Li N, Liu M, Jiao J, et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction. Circulation 2020;142:195673.

Article CAS PubMed Google Scholar

Wang J, Duan Y, Sluijter JP, Xiao J. Lymphocytic subsets play distinct roles in heart diseases. Theranostics 2019;9:403046.

Article CAS PubMed PubMed Central Google Scholar

Yan X, Shichita T, Katsumata Y, Matsuhashi T, Ito H, Ito K, et al. Deleterious effect of the IL-23/IL-17A axis and T cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc. 2012;1:e004408.

Article PubMed PubMed Central Google Scholar

Li L, Luo R, Yang Y, Cheng Y, Ge S, Xu G. Tamibarotene inhibit the accumulation of fibrocyte and alleviate renal fibrosis by IL-17A. Ren Fail. 2020;42:117383.

Article CAS PubMed PubMed Central Google Scholar

Hofmann U, Beyersdorf N, Weirather J, Podolskaya A, Bauersachs J, Ertl G, et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 2012;125:165263.

Article CAS PubMed Google Scholar

Yuan D, Tie J, Xu Z, Liu G, Ge X, Wang Z, et al. Dynamic profile of CD4(+) T-cell-associated cytokines/chemokines following murine myocardial infarction/reperfusion. Mediators Inflamm. 2019;2019:9483647.

Article PubMed PubMed Central Google Scholar

Boag SE, Andreano E, Spyridopoulos I. Lymphocyte communication in myocardial ischemia/reperfusion injury. Antioxid Redox Signal. 2017;26:66075.

Article CAS PubMed Google Scholar

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. [Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol. 2006;10:45089.

Google Scholar

Mand P, Rivero SG, Rizzo MM, Pinkasz M, Levy EM. Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era. Breast. 2021;60:1525.

Article PubMed PubMed Central Google Scholar

Luckheeram RV, Zhou R, Verma AD, Xia B. CD4+T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:925135.

Article PubMed PubMed Central Google Scholar

Zhang J, Fan J, Skwarczynski M, Stephenson RJ, Toth I, Hussein WM. Peptide-based nanovaccines in the treatment of cervical cancer: a review of recent advances. Int J Nanomed. 2022;17:869900.

Article CAS Google Scholar

Bar-Or A, Li R. Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances. Lancet Neurol. 2021;20:47083.

Article CAS PubMed Google Scholar

Li P, Chen Y, Luo L, Yang H, Pan Y. Immunoregulatory effect of Acanthopanax trifoliatus (L.) Merr. Polysaccharide on T1DM mice. Drug Des, Dev Ther. 2021;15:262939.

Article Google Scholar

Bowles AC, Wise RM, Gerstein BY, Thomas RC, Ogelman R, Manayan RC, et al. Adipose stromal vascular fraction attenuates T(H)1 cell-mediated pathology in a model of multiple sclerosis. J Neuroinflammation. 2018;15:77.

Article PubMed PubMed Central Google Scholar

Fu Y, Lin Q, Zhang Z, Zhang L. Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharmaceutica Sin B 2020;10:41433.

Article CAS Google Scholar

Damodharan K, Arumugam GS, Ganesan S, Doble M, Thennarasu S. A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2. RSC Adv. 2021;11:2000635.

Article CAS PubMed PubMed Central Google Scholar

Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4:58394.

Article CAS PubMed PubMed Central Google Scholar

Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, et al. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995;376:5946.

Article CAS PubMed Google Scholar

Go here to read the rest:
The roles of Th cells in myocardial infarction | Cell Death Discovery - Nature.com